Pemetrexed/Cisplatin Intercalating Gefitinib Treating EGFR Wild NSCLC

Clinical trial NCT03374280 · UNKNOWN

Trial details

NCT number: NCT03374280
Sponsor: Guangzhou Medical University
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Non Small Cell Lung Cancer

Start date: 2016-12-01
Primary completion: 2019-12-30
Enrollment: 178

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.